目的 研究特耐针(注射用帕瑞昔布钠)联合心理干预应用于甲状腺癌术后镇痛的临床效果.方法 选取100例2015年7月~2017年4月来院治疗的患者随机分为试验组和对照组.对照组接受特耐针剂治疗,试验组接受特耐针及心理干预联合治疗.2组患者治疗3天后,分别测定2组患者每天特耐平均用药量及SAS、SDS评分.结果 试验组患者每天特耐平均用药量为(45.6±9.7)mg,对照组患者每天特耐平均用药量为(67.9±9.5)mg.对照组患者治疗前SAS为(45.88±7.56)分,治疗后为(50.42±7.91)分;治疗组治疗前SAS为(45.94±7.32)分,治疗后为(40.81±6.61)分.对照组患者治疗前SDS为(45.53±8.62)分,治疗后为(50.29±7.24)分;治疗组治疗前SDS为(45.41±7.18)分,治疗后为(40.36±6.15)分.治疗组均优于对照组,2组差异均具统计学意义(P<0.01).结论 术后心理干预能有效增强特耐针剂的镇痛效果,减少药物使用量,并同时提高心理评分.该治疗方法在临床上值得推广.%Objective To study the clinical effect of parecoxib sodium for injection combined with psychological intervention on postoperative analgesia in the patients with thyroid cancer. Methods 100 patients with thyroid cancer Hangzhou tumor hospitalfrom July 2015 to April 2017 were randomly divided into two groups, the experimental group and the control group. The control group were given parecoxib sodium for injection, and the experimental group were received parecoxib sodium for injection combined with psychological intervention. Three days after treatment, the average amount of parecoxib sodium for injection and SAS, SDS score in the two groups were compared. Results The average dosage of parecoxib sodium for injection in the experimental group was (45.6±9.7) mg, and (67.9±9.5) mg in the control group. In the control group, SAS was (45.88± 7.56)points before treatment and (50.42±7.91) points after treatment, SAS was (45.94±7.32)points before treatment and (40.81 ± 6.61) points after treatment. SDS in the control group before treatment was (45.53±8.62) points and (50.29±7.24) points after treatment. In the experimental group, SDS before treatment was (45.41±7.18) points and (40.36±6.15) after treatment. The differences of all the data were statistically significant in the two gorups(P<0.01). Conclusion Postoperative psychological intervention can effectively enhance the analgesic effect of parecoxib sodium for injection, reduce the dosage and also improve the psychological score. This treatment is worthy of clinical promotion.
展开▼
